HIVE vs NUAI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 30, 2026
HIVE
NUAI
Investment Advisor Scores
NUAI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | HIVE | NUAI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 62.8931 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 73.5% | -82.5% | HIVE |
| Earnings Growth | -99.9% | 0.0% | NUAI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 39.5/100 | 30.7/100 | HIVE |
| Profit Margin | -98.5% | 0.0% | NUAI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | EXTENDED | NUAI |
Relative Price Performance (Last 90 Days)
Current Technical Phase
HIVE
DistributionPrice near a flattening SMA50 (slope -3.2%) with fading momentum, RSI 44
NUAI
MarkupPrice above SMA50, rising 50-day trend (10.4% over 20 days), RSI 54
Fundamentals Snapshot
| Metric | HIVE | NUAI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -5.7 | -24.5 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.7% | -0.8% |
| Gross Margin | 0.4% | 1.0% |
| Operating Margin | -0.6% | -455.7% |
| EPS | -1.39 | -0.99 |
| Dividend Yield | — | — |